SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, has expanded its international footprint with the launch of Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo, powered by its SSi Mantra 3.0 surgical robotic system. The program began with a robotic-assisted left internal mammary artery takedown performed by company founder and Chairman Dr. Sudhir Srivastava alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva, and the hospital reportedly completed more than 25 robotic procedures within the first three weeks.
The launch adds to SS Innovations' international expansion as the company reported 224 cumulative SSi Mantra installations across 12 countries at the end of the second quarter of 2026. Quarterly revenue increased 39% year over year to $13.9 million, while robotic procedures rose 143% to 2,528, highlighting increased utilization of its installed systems and potential opportunities for recurring revenue from surgical instruments and consumables. SS Innovations is also pursuing broader market access, with U.S. FDA clearance targeted for the first quarter of 2027 and European CE marking targeted for the end of 2026. To view the full article, visit https://nnw.fm/DJ6dI.
The significance of this announcement extends beyond a single hospital. Robotic cardiac surgery is among the most complex applications of surgical robotics, and its successful deployment in Sri Lanka demonstrates the versatility and reliability of the SSi Mantra 3.0 system. For patients in the region, this means access to minimally invasive cardiac procedures that can lead to shorter recovery times and reduced trauma compared to traditional open-heart surgery. For SS Innovations, the program serves as a showcase for its technology in a new market and reinforces its strategy of making robotic surgery affordable and accessible to a larger segment of the global population.
SS Innovations International develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The company's product range includes its proprietary "SSi Mantra" surgical robotic system and its comprehensive suite of "SSi Mudra" surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the company's website at SSInnovations.com for more information and updates.
NOTE TO INVESTORS: The latest news and updates relating to SSII are available in the company's newsroom at https://nnw.fm/SSII.
About NetworkNewsWire: NetworkNewsWire ("NNW") is a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions.
